Arterial Remodeling Technologies
Arterial Remodeling Technologies said it won CE Mark approval in the European Union for its bioreabsorbable stent for treating coronary artery disease.
Arterial Remodeling Technologies, a French company whose technology was developed in part by the Cleveland Clinic, has raised $8.5 million in venture capital funding to further develop its biodegradable stents.
Fred Cornhill, former chairman of the Clinic’s department of biomedical engineering, worked with researchers at two French institutions to develop the device. Cleveland Clinic maintains an equity stake in the company, according to Chris Coburn, executive director of Cleveland Clinic Innovations.